Cargando…

A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2

SIMPLE SUMMARY: The miR-29 family is subjected to complex regulation by tumor suppressors and oncogenes and has tumor suppressive potential in several cancers. We demonstrate that, in melanoma, oncogenic BRAF paradoxically induces miR-29 in concert with p53, thereby forming a barrier to melanoma pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vera, Olga, Bok, Ilah, Jasani, Neel, Nakamura, Koji, Xu, Xiaonan, Mecozzi, Nicol, Angarita, Ariana, Wang, Kaizhen, Tsai, Kenneth Y., Karreth, Florian A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003541/ https://www.ncbi.nlm.nih.gov/pubmed/33808771 http://dx.doi.org/10.3390/cancers13061408

Ejemplares similares

A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities
por: Bok, Ilah, et al.
Publicado: (2021)

Genetic tools for the stable overexpression of circular RNAs
por: Mecozzi, Nicol, et al.
Publicado: (2022)

A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism
por: Pradas-Juni, Marta, et al.
Publicado: (2020)

Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma
por: Zhong, Feiliang, et al.
Publicado: (2022)

LncRNA MAFG-AS1 is involved in human cancer progression
por: Li, Penghui, et al.
Publicado: (2023)

MAFG‐AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma
por: Xiao, Mengqing, et al.
Publicado: (2020)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation
por: Lv, Jiadi, et al.
Publicado: (2023)

Regulatory effect of the MAFG-AS1/miR-150-5p/MYB axis on the proliferation and migration of breast cancer cells
por: Jia, Hongyao, et al.
Publicado: (2020)

Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks
por: Hirotsu, Yosuke, et al.
Publicado: (2012)

Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis
por: Zhang, Kui, et al.
Publicado: (2018)

PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer
por: He, Qiuming, et al.
Publicado: (2023)

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
por: Liu, Qian, et al.
Publicado: (2021)

miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells
por: Caggiano, Rocco, et al.
Publicado: (2017)

MYB/MYBL1::QKI fusion-positive diffuse glioma
por: Suh, Ye Yoon, et al.
Publicado: (2023)

Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis
por: Sun, Xi, et al.
Publicado: (2020)

LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis
por: Mu, Xiangyu, et al.
Publicado: (2022)

MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX
por: Ye, Liqing, et al.
Publicado: (2020)

MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
por: Clarke, M, et al.
Publicado: (2013)

Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients
por: Jia, Yongxu, et al.
Publicado: (2019)

MYBL2 and ATM suppress replication stress in pluripotent stem cells
por: Blakemore, Daniel, et al.
Publicado: (2021)

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022)

DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells
por: Vera, Olga, et al.
Publicado: (2017)

MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
por: VERA-PUENTE, OLGA, et al.
Publicado: (2018)

MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
por: Shan, Hua-jian, et al.
Publicado: (2021)

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy
por: Heinrichs, Stefan, et al.
Publicado: (2013)

Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
por: Le, Lulu, et al.
Publicado: (2021)

MYBL2 Gene Polymorphism Is Associated With Acute Lymphoblastic Leukemia Susceptibility in Children
por: Guo, Haixia, et al.
Publicado: (2021)

The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages
por: Pan, Baoyue, et al.
Publicado: (2023)

LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis
por: Qian, Cui-juan, et al.
Publicado: (2020)

LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells
por: Tang, Chenye, et al.
Publicado: (2021)

LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression
por: Ye, Chen, et al.
Publicado: (2022)

LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation
por: Zhao, Hao, et al.
Publicado: (2021)

Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2
por: Fu, Junqi, et al.
Publicado: (2022)

Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells
por: Lee, Yuri, et al.
Publicado: (2022)

A Mutation in the MYBL2-1 Gene Is Associated with Purple Pigmentation in Brassica oleracea
por: Khusnutdinov, Emil, et al.
Publicado: (2022)

Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway
por: Di, Shihao, et al.
Publicado: (2022)

Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming
por: Ward, Carl, et al.
Publicado: (2018)

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
por: Qin, Hui, et al.
Publicado: (2019)

MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer
por: Jiao, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlu07f1f7sep7555tg4m7abdnt